✦ LIBER ✦

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation

✍ Scribed by M. Schmidt; M. B. Johansen; D. J. Robertson; M. Maeng; A. Kaltoft; L. O. Jensen; H.-H. Tilsted; H. E. Bøtker; H. T. Sørensen; J. A. Baron

Book ID: 108606507
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 169 KB
Volume: 35
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2011.04890.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prophylactic use of a proton pump in

The prophylactic use of a proton pump inhibitor (PPI) in patients treated with clopidogrel and aspirin for an acute coronary syndrome or placement of a coronary stent reduces the rate of upper gastrointestinal bleeding with no apparent increase in cardiovascular events

✍ Simona Sada; Giorgio Costantino 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 114 KB